Skip to content
Wenlo
Sign in
← Markets

ResMed Inc.

Michael J. Farrell (Chairman and CEO) reports RMD insider transactions

4RMDFiled Nov 20, 2026, 7:27 PM ET· Period Nov 19, 2026

AI-generated summary

Chairman and CEO, Director Michael J. Farrell received 48,136 shares as a grant on November 19, 2026. On the same date, 28,180.245 shares were disposed of for a tax withholding at an average price of $236.88, valued at $6,675,336.44. Following these transactions, the insider directly held 491,729 shares of ResMed Common Stock.

Key facts

Insider
Michael J. Farrell · Chairman and CEO, Director
DateTransactionSharesPriceValueHeld afterOwnership
Nov 19, 2026A · grantFootnotes F1+48,136$0.00$0.00519,910Direct
Nov 19, 2026F · tax withholdingFootnotes F2−28,180.245$236.88$6,675,336.44491,729Direct
Footnotes
  1. F1 Represents performance-based restricted stock units granted on November 16, 2023. The shares were earned on November 19, 2026, when the compensation and leadership development committee certified that the performance metrics were met for this portion of the grant.
  2. F2 Disposition to issuer for tax withholding on vesting of performance-based restricted stock units granted on 11/16/2023.

More RMD filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.